CAS RN 1020172-07-9

IUPAC Name: —

Synonyms: —

Molecular Weight (g/mol): —

Molecular Formula: —

InChi Key: —

SMILES: —

Grade

Molecular Weight (g/mol)

Percent Purity

Physical Form

Quantity

MedChemExpress Rebastinib (DCC-2036) is an orally active, non-ATP-competitive Bcr-Abl inhibitor for Abl1WT and Abl1T315I with IC50s of 0.8 nM and 4 nM, respectively. Rebastinib also inhibits SRC, KDR, FLT3, and Tie-2, and has low activity to seen towards c-Kit.

Pricing and Availability
Specifications

Molecular Weight (g/mol)	553.59
Color	Off-White
Physical Form	Powder
Chemical Name or Material	Rebastinib
Grade	Research
SMILES	CC(C)(C)C1=NN(C(NC(NC2=C(F)C=C(OC3=CC(C(NC)=O)=NC=C3)C=C2)=O)=C1)C4=CC=C5C(C=CC=N5)=C4
For Use With (Application)	Cancer-Kinase/protease
Percent Purity	98.0%
CAS	1020172-07-9
Solubility Information	DMSO : 50 mg/mL (90.32 mM; ultrasonic and warming and heat to 80°C)
Synonym	DCC-2036
Purity Grade Notes	Research
Recommended Storage	Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month
Shelf Life	Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month
Molecular Formula	C₃₀H₂₈FN₇O₃
Formula Weight	553.59

CAS RN 1020172-07-9

CAS RN 1020172-07-9

Filtered Search Results

Narrow Results